Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02923531
Title Addition of X4P-001 to Nivolumab Treatment in Patients With Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors X4 Pharmaceuticals

renal cell carcinoma


Nivolumab + X4P-001

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington District of Columbia United States Details
Boston Massachusetts United States Details
Hackensack New Jersey United States Details
Chapel Hill North Carolina United States Details
*Shaded cells indicate that there was no data available from for the field